M&T Bank Corp Quotient LTD Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 05, 2022	SELL	$0.24 - $1.2 $775 - $3,877	-3,231 Reduced 5.47%	55,867 $12,000
Q1 2022 May 09, 2022	BUY	$0.94 - $2.38 $4,523 - $11,452	4,812 Added 8.86%	59,098 $71,000
Q4 2021 Feb 07, 2022	BUY	$1.89 - $3.12 $1,646 - $2,717	871 Added 1.63%	54,286 $141,000
Q3 2021 Oct 28, 2021	BUY	$2.34 - $3.77 $12,764 - $20,565	5,455 Added 11.37%	53,415 $126,000
Q2 2021 Aug 13, 2021	SELL	$3.48 - $4.45 $6,789 - $8,681	-1,951 Reduced 3.91%	47,960 $174,000
Q1 2021 May 06, 2021	SELL	$3.57 - $6.2 $61,860 - $107,433	-17,328 Reduced 25.77%	49,911 $184,000
Q4 2020 Feb 12, 2021	SELL	$4.4 - $7.32 $263,837 - $438,929	-59,963 Reduced 47.14%	67,239 $350,000
Q3 2020 Nov 06, 2020	BUY	$4.38 - $8.35 $141,141 - $269,070	32,224 Added 33.93%	127,202 $654,000
Q2 2020 Jul 29, 2020	BUY	$3.64 - $9.26 $88,459 - $225,036	24,302 Added 34.39%	94,978 $702,000
Q1 2020 May 14, 2020	BUY	$2.54 - $9.38 $59,646 - $220,270	23,483 Added 49.76%	70,676 $278,000
Q4 2019 Feb 07, 2020	BUY	$7.07 - $9.51 $81,580 - $109,735	11,539 Added 32.36%	47,193 $449,000
Q3 2019 Nov 12, 2019	BUY	$7.77 - $11.26 $60,357 - $87,467	7,768 Added 27.86%	35,654 $276,000
Q2 2019 Aug 12, 2019	BUY	$7.91 - $10.25 $47,910 - $62,084	6,057 Added 27.75%	27,886 $261,000
Q1 2019 May 15, 2019	BUY	$6.0 - $11.07 $69,654 - $128,511	11,609 Added 113.59%	21,829 $197,000
Q4 2018 Feb 01, 2019	SELL	$5.81 - $7.89 $4,770 - $6,477	-821 Reduced 7.44%	10,220 $62,000
Q3 2018 Nov 09, 2018	BUY	$6.57 - $8.31 $72,539 - $91,750	11,041 New	11,041 $84,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.